Defective X-chromosome inactivation and cancer risk in women

Related articles

1. Gain of chromosome 17 is an early genetic abnormality in neuroblastoma with PPM1D emerging as a strong candidate oncogene driving tumor progression

   This article has 25 authors:

   1. Jelena Milosevic
   2. Susanne Fransson
   3. Johanna Svensson
   4. Jörg Otte
   5. Thale K. Olsen
   6. Baldur Sveinbjornsson
   7. Falk Hertwig
   8. Christoph Bartenhagen
   9. Frida Abel
   10. Susanne E. Reinsbach
   11. Anna Djos
   12. Niloufar Javanmardi
   13. Yao Shi
   14. Jane Y Hehir-Kwa
   15. Arjen Mensenkamp
   16. Godelieve AM Tytgat
   17. Johan Holmberg
   18. Jan J Molenaar
   19. Marjolijn Jongmans
   20. Matthias Fischer
   21. Ninib Baryawno
   22. David Gisselsson
   23. Tommy Martinsson
   24. Per Kogner
   25. John Inge Johnsen

2. Genetic drivers and clinical consequences of mosaic chromosomal alterations in 1 million individuals

   This article has 18 authors:

   1. Kun Zhao
   2. Yash Pershad
   3. Hannah M Poisner
   4. Xiaolong Ma
   5. Kali Quade
   6. Caitlyn Vlasschaert
   7. Taralynn Mack
   8. Nikhil K Khankari
   9. Kelly von Beck
   10. James Brogan
   11. Ashwin Kishtagari
   12. Robert W Corty
   13. Yajing Li
   14. Yaomin Xu
   15. Alexander P Reiner
   16. Paul Scheet
   17. Paul L Auer
   18. Alexander G Bick

3. Human genomic regions of systemic interindividual epigenetic variation are implicated in neurodevelopmental and metabolic disorders

   This article has 16 authors:

   1. Wen-Jou Chang
   2. Uditha Maduranga
   3. Chathura J. Gunasekara
   4. Alan Yang
   5. Matthew Hirschtritt
   6. Katrina Rodriguez
   7. Cristian Coarfa
   8. Goo Jun
   9. Craig L. Hanis
   10. James M. Flanagan
   11. Ivan P. Gorlov
   12. Christopher I. Amos
   13. Joseph L. Wiemels
   14. Catherine A. Schaefer
   15. Ezra S. Susser
   16. Robert A. Waterland